Menu
Your search for “Reliable HL7-FHIR Dumps - HL7 HL7 FHIR STU3 Proficiency Realistic Reliable Dumps Pass Guaranteed 💦 Open website ➠ www.pdfvce.com 🠰 and search for ➥ HL7-FHIR 🡄 for free download 🧐HL7-FHIR Reliable Test Labs” returned the following results.
Wearables, Sensors, and Apps Part 1 – Updates on FDA’s PDUFA VII Goals for the Use of Digital Health Technologies in Drug and Biological Product Development
…or workshops with key stakeholders including patients, biopharmaceutical companies, DHT companies, and academia to gather input into issues related to the use of DHTs in regulatory decision-making. By the end…
A New Wrinkle in Generic ACTOS 180-Day Exclusivity; What Might it Mean for Post-MMA Exclusivity?
By Kurt R. Karst – A rather interesting and unexpected (to most) ANDA approval popped up on FDA’s website late last week. On February 6, 2013, FDA approved Macleods Pharmaceuticals…
FDA Announces FSMA Tour
…how to submit comments, data, and other information to the rulemaking docket; to respond to questions about the proposed rules; and to provide an opportunity for interested persons to make…
HP&M’s Dave Clissold to Speak at Management Forum Conference on Drug Regulatory Strategy Matters
…price of the two-day conference. To receive the discount, please contact Sarah Packham at sarah.packham@management-forum.co.uk and mention FDA Law Blog. For more information and to register, visit the conference website….
HP&M’s Dave Clissold to Speak at Management Forum Conference on Orphan Drug, Regulatory Strategy Matters, and More
…off the conference registration price. To receive the discount, please contact Sarah Packham at sarah.packham@management-forum.co.uk and mention FDA Law Blog. For more information and to register, visit the conference website. …
Congressman Markey Introduces Legislation Increasing Regulatory Oversight of Pharmaceutical Compounding
…and Commerce Committee, introduced legislation that will attempt to strengthen federal oversight of compounding pharmacies. NECC, which is located in Congressman Markey’s congressional district, is the alleged source of injectable…
Excuses, Excuses! A Round-Up of Exceptions Under the Failure to Obtain Timely Tentative Approval 180-Day Exclusivity Forfeiture Provision
…dosage form products.” As we previously reported, FDA has issued letters to companies with pending ANDAs stating that the applications are not approvable because of tablet size differences when compared…
FDA Sued Over Generic DIOVAN 180-Day Exclusivity; Lawsuit Takes Issue With FDA Forfeiture Decision and “Trust Me” Approach to Exclusivity Decisions
…timely tentative approval” forfeiture provision at FDC Act § 505(j)(5)(D)(i)(IV). That day has finally come. Earlier this week, Mylan Laboratories Limited and Mylan Pharmaceuticals Inc. (collectively, “Mylan”) filed a Complaint…
The Obesity Epidemic: FDA’s Growing Waistline!
…bias. In other words, we would need to find a resource that would allow us to compare apples to apples. It turns out that such a resource is readily available. …
The Rise of eSTAR for Medical Device De Novo Submissions
…must be conducted and completed within 15 calendar days of FDA receiving a De Novo request. The draft guidance notes that “[i]f the eSTAR is not complete when submitted, FDA…